浩欧博上周获融资净买入1558.82万元，居两市第472位

Core Viewpoint - Jiangsu Haobo Bio-Pharmaceutical Co., Ltd. has shown significant financing activity, with a net financing inflow of 15.5882 million yuan last week, indicating investor interest in the company [1][2]. Group 1: Financing Activity - Haobo received a total financing inflow of 154 million yuan and repaid 139 million yuan last week [1]. - Over the past five days, the main capital inflow was 87.7547 million yuan, with a price increase of 8.87% [2]. - In the last ten days, the main capital inflow was 50.6894 million yuan, with a price increase of 2.7% [2]. Group 2: Company Profile - Jiangsu Haobo Bio-Pharmaceutical Co., Ltd. was established in 2009 and is located in Suzhou, primarily engaged in the pharmaceutical manufacturing industry [2]. - The company has a registered capital of 63.058328 million yuan, which is also its paid-in capital [2]. - The legal representative of the company is John Li [2]. Group 3: Investment and Intellectual Property - Haobo has made investments in six companies and participated in 181 bidding projects [2]. - The company holds 41 trademark registrations and 112 patent registrations, along with 505 administrative licenses [2].